← Leaderboards
Prasad V. S. Kanteti
University Of Illinois At Chicago
$1,771,347
Attributed
$3,120,891
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $959.2K · FY2017–19$1M$750K$500K$250K$0
'17
'18
'19
Funding mix
By agency
NIH$3,120,891 · 2
By mechanism
R42$2,699,089 · 1
R01$421,802 · 1
Top collaborators
- Asrar B. Malik3 shared
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Asgerally T. Fazleabas$18,735,438
- Joanna E Burdette$8,615,329
- Arshad Rahman$8,589,196
- Asrar B. Malik$58,182,625
- You-Yang Zhao$24,398,532
Others in their field
Top investigators on “Cytokine”
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$83,965,880
- David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
- Fulton T Crews · University Of North Carolina Chapel Hill$36,249,590
- Marianne Ward · Duke University$34,872,957
- Joren C Madsen · Massachusetts General Hospital$33,058,731
- Barton F Haynes · Duke University$29,068,807
Research focus
CytokineDefense ResponseCommercializationCritical IllnessAging PopulationClinical PharmacologyAdult Respiratory Distress SyndromeCombatAcute Lung InjuryAcute Respiratory FailureBacterial PneumoniaBaseAlbuminsAdmission ActivityAnimal ModelCardiovascular PhysiologyAnti-InflammatoryClinical TrialsAffectCellsCell SurfaceClinicClinical DataDose
Grant awards (5)
Albumin Nanoparticles Incorporating Piceatannol (PANPs) for ALI/ARDS therapy$872,742
R42 · FY2019 · HL
Albumin Nanoparticles Incorporating Piceatannol (PANPs) for ALI/ARDS therapy$867,135
R42 · FY2018 · HL
Albumin Nanoparticles Incorporating Piceatannol (PANPs) for ALI/ARDS therapy$959,212
R42 · FY2017 · HL
SIGNALING THROUGH CD27, A MEMBER OF THE TNFR FAMILY$213,983
R01 · FY2001 · GM
SIGNALING THROUGH CD27, A MEMBER OF THE TNFR FAMILY$207,819
R01 · FY2000 · GM